nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PIK3CD—pancreatic cancer	0.181	0.361	CbGaD
Caffeine—PIK3CB—pancreatic cancer	0.181	0.361	CbGaD
Caffeine—PIK3CA—pancreatic cancer	0.14	0.279	CbGaD
Caffeine—CYP1B1—Tamoxifen—pancreatic cancer	0.0282	0.0881	CbGbCtD
Caffeine—CYP1B1—Erlotinib—pancreatic cancer	0.024	0.0749	CbGbCtD
Caffeine—CYP1B1—Docetaxel—pancreatic cancer	0.0159	0.0496	CbGbCtD
Caffeine—CYP1A1—Dacarbazine—pancreatic cancer	0.0156	0.0486	CbGbCtD
Caffeine—CYP1A1—Tamoxifen—pancreatic cancer	0.0124	0.0387	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—pancreatic cancer	0.012	0.0375	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—pancreatic cancer	0.0118	0.037	CbGbCtD
Caffeine—CYP1A1—Erlotinib—pancreatic cancer	0.0105	0.0329	CbGbCtD
Caffeine—CYP3A7—Tamoxifen—pancreatic cancer	0.00991	0.0309	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.00991	0.0309	CbGbCtD
Caffeine—CYP2E1—Tamoxifen—pancreatic cancer	0.00957	0.0299	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.00761	0.0238	CbGbCtD
Caffeine—CYP3A7—Irinotecan—pancreatic cancer	0.00761	0.0238	CbGbCtD
Caffeine—CYP3A5—Tamoxifen—pancreatic cancer	0.00743	0.0232	CbGbCtD
Caffeine—CYP2C8—Tamoxifen—pancreatic cancer	0.00715	0.0223	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—pancreatic cancer	0.00695	0.0217	CbGbCtD
Caffeine—CYP3A5—Erlotinib—pancreatic cancer	0.00632	0.0197	CbGbCtD
Caffeine—CYP2C8—Erlotinib—pancreatic cancer	0.00608	0.019	CbGbCtD
Caffeine—CYP3A5—Irinotecan—pancreatic cancer	0.00571	0.0178	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00558	0.0174	CbGbCtD
Caffeine—CYP3A7—Docetaxel—pancreatic cancer	0.00558	0.0174	CbGbCtD
Caffeine—CYP3A7—Sunitinib—pancreatic cancer	0.00555	0.0173	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00555	0.0173	CbGbCtD
Caffeine—CYP1A2—Tamoxifen—pancreatic cancer	0.00553	0.0173	CbGbCtD
Caffeine—CYP2C8—Fluorouracil—pancreatic cancer	0.00527	0.0164	CbGbCtD
Caffeine—CYP2C9—Tamoxifen—pancreatic cancer	0.00498	0.0156	CbGbCtD
Caffeine—ABCB1—Tamoxifen—pancreatic cancer	0.00484	0.0151	CbGbCtD
Caffeine—CYP1A2—Erlotinib—pancreatic cancer	0.0047	0.0147	CbGbCtD
Caffeine—CYP2D6—Tamoxifen—pancreatic cancer	0.00456	0.0142	CbGbCtD
Caffeine—Sodium high—Sunitinib—pancreatic cancer	0.0044	0.0715	CcSEcCtD
Caffeine—CYP3A5—Docetaxel—pancreatic cancer	0.00418	0.0131	CbGbCtD
Caffeine—ABCB1—Gemcitabine—pancreatic cancer	0.00417	0.013	CbGbCtD
Caffeine—CYP3A5—Sunitinib—pancreatic cancer	0.00416	0.013	CbGbCtD
Caffeine—ABCB1—Erlotinib—pancreatic cancer	0.00411	0.0128	CbGbCtD
Caffeine—CYP1A2—Fluorouracil—pancreatic cancer	0.00408	0.0127	CbGbCtD
Caffeine—CYP2D6—Erlotinib—pancreatic cancer	0.00388	0.0121	CbGbCtD
Caffeine—ABCB1—Irinotecan—pancreatic cancer	0.00371	0.0116	CbGbCtD
Caffeine—Ca++ increased—Sunitinib—pancreatic cancer	0.00368	0.0598	CcSEcCtD
Caffeine—CYP2C9—Fluorouracil—pancreatic cancer	0.00367	0.0115	CbGbCtD
Caffeine—Blood sodium increased—Sunitinib—pancreatic cancer	0.00318	0.0517	CcSEcCtD
Caffeine—CYP3A4—Tamoxifen—pancreatic cancer	0.0029	0.00905	CbGbCtD
Caffeine—Necrotising enterocolitis neonatal—Docetaxel—pancreatic cancer	0.00279	0.0453	CcSEcCtD
Caffeine—Necrotizing enterocolitis—Docetaxel—pancreatic cancer	0.00279	0.0453	CcSEcCtD
Caffeine—ABCB1—Docetaxel—pancreatic cancer	0.00272	0.0085	CbGbCtD
Caffeine—ABCB1—Sunitinib—pancreatic cancer	0.00271	0.00846	CbGbCtD
Caffeine—CYP3A4—Erlotinib—pancreatic cancer	0.00246	0.00769	CbGbCtD
Caffeine—Necrotising colitis—Docetaxel—pancreatic cancer	0.00228	0.037	CcSEcCtD
Caffeine—CYP3A4—Irinotecan—pancreatic cancer	0.00223	0.00695	CbGbCtD
Caffeine—ABCB1—Doxorubicin—pancreatic cancer	0.00203	0.00634	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—pancreatic cancer	0.00191	0.00597	CbGbCtD
Caffeine—CYP3A4—Docetaxel—pancreatic cancer	0.00163	0.00509	CbGbCtD
Caffeine—CYP3A4—Sunitinib—pancreatic cancer	0.00162	0.00507	CbGbCtD
Caffeine—Necrotising colitis—Epirubicin—pancreatic cancer	0.00154	0.025	CcSEcCtD
Caffeine—Necrotising colitis—Doxorubicin—pancreatic cancer	0.00142	0.0231	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Sunitinib—pancreatic cancer	0.00129	0.021	CcSEcCtD
Caffeine—PRKDC—islet of Langerhans—pancreatic cancer	0.00123	0.118	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—pancreatic cancer	0.00122	0.0038	CbGbCtD
Caffeine—Impaired healing—Sunitinib—pancreatic cancer	0.00107	0.0173	CcSEcCtD
Caffeine—PIK3CA—islet of Langerhans—pancreatic cancer	0.000999	0.0956	CbGeAlD
Caffeine—Cerebral haemorrhage—Erlotinib—pancreatic cancer	0.000963	0.0156	CcSEcCtD
Caffeine—PRKDC—pancreas—pancreatic cancer	0.000868	0.083	CbGeAlD
Caffeine—PIK3CD—pancreas—pancreatic cancer	0.000814	0.0778	CbGeAlD
Caffeine—ATM—digestive system—pancreatic cancer	0.000784	0.075	CbGeAlD
Caffeine—Hypercalcaemia—Tamoxifen—pancreatic cancer	0.000776	0.0126	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Docetaxel—pancreatic cancer	0.000736	0.012	CcSEcCtD
Caffeine—PIK3CB—pancreas—pancreatic cancer	0.00071	0.0679	CbGeAlD
Caffeine—PIK3CA—pancreas—pancreatic cancer	0.000702	0.0672	CbGeAlD
Caffeine—PIK3CD—digestive system—pancreatic cancer	0.000695	0.0665	CbGeAlD
Caffeine—Haemoglobin decreased—Sunitinib—pancreatic cancer	0.000671	0.0109	CcSEcCtD
Caffeine—Hypercalcaemia—Sunitinib—pancreatic cancer	0.000664	0.0108	CcSEcCtD
Caffeine—Accidental injury—Tamoxifen—pancreatic cancer	0.000609	0.00989	CcSEcCtD
Caffeine—PIK3CB—digestive system—pancreatic cancer	0.000606	0.058	CbGeAlD
Caffeine—PIK3CA—digestive system—pancreatic cancer	0.0006	0.0574	CbGeAlD
Caffeine—Creatinine increased—Tamoxifen—pancreatic cancer	0.000566	0.0092	CcSEcCtD
Caffeine—Creatinine increased—Sunitinib—pancreatic cancer	0.000485	0.00788	CcSEcCtD
Caffeine—Sepsis—Tamoxifen—pancreatic cancer	0.000468	0.0076	CcSEcCtD
Caffeine—Sepsis—Erlotinib—pancreatic cancer	0.000463	0.00752	CcSEcCtD
Caffeine—Accidental injury—Irinotecan—pancreatic cancer	0.00043	0.00698	CcSEcCtD
Caffeine—Injury—Tamoxifen—pancreatic cancer	0.000426	0.00691	CcSEcCtD
Caffeine—Pulmonary oedema—Sunitinib—pancreatic cancer	0.000411	0.00667	CcSEcCtD
Caffeine—Sepsis—Sunitinib—pancreatic cancer	0.000401	0.00651	CcSEcCtD
Caffeine—PDE4B—islet of Langerhans—pancreatic cancer	0.000391	0.0374	CbGeAlD
Caffeine—Creatinine increased—Gemcitabine—pancreatic cancer	0.000389	0.00632	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Erlotinib—pancreatic cancer	0.000387	0.00629	CcSEcCtD
Caffeine—Haemoglobin decreased—Docetaxel—pancreatic cancer	0.000382	0.0062	CcSEcCtD
Caffeine—Blood creatinine increased—Tamoxifen—pancreatic cancer	0.000367	0.00595	CcSEcCtD
Caffeine—Dry skin—Erlotinib—pancreatic cancer	0.000355	0.00576	CcSEcCtD
Caffeine—Hypoglycaemia—Sunitinib—pancreatic cancer	0.000343	0.00558	CcSEcCtD
Caffeine—Gastritis—Erlotinib—pancreatic cancer	0.000343	0.00556	CcSEcCtD
Caffeine—Sepsis—Irinotecan—pancreatic cancer	0.00033	0.00536	CcSEcCtD
Caffeine—Pulmonary oedema—Gemcitabine—pancreatic cancer	0.00033	0.00536	CcSEcCtD
Caffeine—Sepsis—Gemcitabine—pancreatic cancer	0.000321	0.00522	CcSEcCtD
Caffeine—Sepsis—Fluorouracil—pancreatic cancer	0.000316	0.00513	CcSEcCtD
Caffeine—Blood creatinine increased—Sunitinib—pancreatic cancer	0.000314	0.0051	CcSEcCtD
Caffeine—Dry skin—Sunitinib—pancreatic cancer	0.000307	0.00499	CcSEcCtD
Caffeine—Deafness—Gemcitabine—pancreatic cancer	0.000301	0.00488	CcSEcCtD
Caffeine—Injury—Irinotecan—pancreatic cancer	0.0003	0.00488	CcSEcCtD
Caffeine—Infestation—Erlotinib—pancreatic cancer	0.000298	0.00485	CcSEcCtD
Caffeine—Infestation NOS—Erlotinib—pancreatic cancer	0.000298	0.00485	CcSEcCtD
Caffeine—Renal failure—Erlotinib—pancreatic cancer	0.000293	0.00476	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.000276	0.00448	CcSEcCtD
Caffeine—PDE4B—pancreas—pancreatic cancer	0.000275	0.0263	CbGeAlD
Caffeine—Haemoglobin—Tamoxifen—pancreatic cancer	0.000272	0.00442	CcSEcCtD
Caffeine—Haemorrhage—Tamoxifen—pancreatic cancer	0.000271	0.0044	CcSEcCtD
Caffeine—Haemoglobin—Erlotinib—pancreatic cancer	0.000269	0.00437	CcSEcCtD
Caffeine—Haemorrhage—Erlotinib—pancreatic cancer	0.000268	0.00435	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.000264	0.00429	CcSEcCtD
Caffeine—Hyperglycaemia—Sunitinib—pancreatic cancer	0.000261	0.00424	CcSEcCtD
Caffeine—Blood creatinine increased—Irinotecan—pancreatic cancer	0.000259	0.0042	CcSEcCtD
Caffeine—Infestation—Sunitinib—pancreatic cancer	0.000258	0.00419	CcSEcCtD
Caffeine—Infestation NOS—Sunitinib—pancreatic cancer	0.000258	0.00419	CcSEcCtD
Caffeine—Hypercalcaemia—Epirubicin—pancreatic cancer	0.000255	0.00415	CcSEcCtD
Caffeine—Renal failure—Sunitinib—pancreatic cancer	0.000254	0.00412	CcSEcCtD
Caffeine—Irritability—Fluorouracil—pancreatic cancer	0.000252	0.0041	CcSEcCtD
Caffeine—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.000252	0.00409	CcSEcCtD
Caffeine—Dry skin—Fluorouracil—pancreatic cancer	0.000242	0.00394	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—pancreatic cancer	0.000236	0.00384	CcSEcCtD
Caffeine—Pulmonary oedema—Docetaxel—pancreatic cancer	0.000234	0.0038	CcSEcCtD
Caffeine—Malnutrition—Erlotinib—pancreatic cancer	0.000233	0.00379	CcSEcCtD
Caffeine—Haemoglobin—Sunitinib—pancreatic cancer	0.000233	0.00378	CcSEcCtD
Caffeine—Haemorrhage—Sunitinib—pancreatic cancer	0.000232	0.00377	CcSEcCtD
Caffeine—CYP3A5—islet of Langerhans—pancreatic cancer	0.000231	0.0221	CbGeAlD
Caffeine—Sepsis—Docetaxel—pancreatic cancer	0.000228	0.00371	CcSEcCtD
Caffeine—Cardiac disorder—Sunitinib—pancreatic cancer	0.000215	0.00349	CcSEcCtD
Caffeine—Deafness—Docetaxel—pancreatic cancer	0.000213	0.00346	CcSEcCtD
Caffeine—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00021	0.00341	CcSEcCtD
Caffeine—Immune system disorder—Sunitinib—pancreatic cancer	0.000209	0.0034	CcSEcCtD
Caffeine—Renal failure—Irinotecan—pancreatic cancer	0.000209	0.0034	CcSEcCtD
Caffeine—Infestation NOS—Fluorouracil—pancreatic cancer	0.000204	0.00331	CcSEcCtD
Caffeine—Infestation—Fluorouracil—pancreatic cancer	0.000204	0.00331	CcSEcCtD
Caffeine—Renal failure—Gemcitabine—pancreatic cancer	0.000204	0.00331	CcSEcCtD
Caffeine—Hypertension—Tamoxifen—pancreatic cancer	0.000203	0.0033	CcSEcCtD
Caffeine—Malnutrition—Sunitinib—pancreatic cancer	0.000202	0.00328	CcSEcCtD
Caffeine—CYP1B1—digestive system—pancreatic cancer	0.000201	0.0192	CbGeAlD
Caffeine—Haemoglobin—Irinotecan—pancreatic cancer	0.000192	0.00312	CcSEcCtD
Caffeine—Infection—Tamoxifen—pancreatic cancer	0.000191	0.0031	CcSEcCtD
Caffeine—Haemorrhage—Irinotecan—pancreatic cancer	0.000191	0.0031	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000191	0.0031	CcSEcCtD
Caffeine—Infection—Erlotinib—pancreatic cancer	0.000189	0.00307	CcSEcCtD
Caffeine—Haemoglobin—Gemcitabine—pancreatic cancer	0.000187	0.00304	CcSEcCtD
Caffeine—Nervous system disorder—Erlotinib—pancreatic cancer	0.000187	0.00303	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—pancreatic cancer	0.000186	0.00303	CcSEcCtD
Caffeine—Haemorrhage—Gemcitabine—pancreatic cancer	0.000186	0.00302	CcSEcCtD
Caffeine—Skin disorder—Erlotinib—pancreatic cancer	0.000185	0.003	CcSEcCtD
Caffeine—Haemoglobin—Fluorouracil—pancreatic cancer	0.000184	0.00299	CcSEcCtD
Caffeine—Haemorrhage—Fluorouracil—pancreatic cancer	0.000183	0.00297	CcSEcCtD
Caffeine—Cardiac disorder—Irinotecan—pancreatic cancer	0.000177	0.00288	CcSEcCtD
Caffeine—Dry skin—Docetaxel—pancreatic cancer	0.000175	0.00284	CcSEcCtD
Caffeine—Convulsion—Sunitinib—pancreatic cancer	0.000175	0.00284	CcSEcCtD
Caffeine—Hypertension—Sunitinib—pancreatic cancer	0.000174	0.00283	CcSEcCtD
Caffeine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000173	0.0028	CcSEcCtD
Caffeine—Immune system disorder—Irinotecan—pancreatic cancer	0.000172	0.0028	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—pancreatic cancer	0.000172	0.0028	CcSEcCtD
Caffeine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000171	0.00278	CcSEcCtD
Caffeine—Dyspnoea—Erlotinib—pancreatic cancer	0.00017	0.00276	CcSEcCtD
Caffeine—Immune system disorder—Gemcitabine—pancreatic cancer	0.000168	0.00273	CcSEcCtD
Caffeine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000166	0.0027	CcSEcCtD
Caffeine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000164	0.00267	CcSEcCtD
Caffeine—Infection—Sunitinib—pancreatic cancer	0.000164	0.00266	CcSEcCtD
Caffeine—CYP3A5—pancreas—pancreatic cancer	0.000163	0.0156	CbGeAlD
Caffeine—Nervous system disorder—Sunitinib—pancreatic cancer	0.000162	0.00262	CcSEcCtD
Caffeine—Skin disorder—Sunitinib—pancreatic cancer	0.00016	0.0026	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.000158	0.00256	CcSEcCtD
Caffeine—Sepsis—Epirubicin—pancreatic cancer	0.000154	0.0025	CcSEcCtD
Caffeine—Infestation—Docetaxel—pancreatic cancer	0.000147	0.00239	CcSEcCtD
Caffeine—Infestation NOS—Docetaxel—pancreatic cancer	0.000147	0.00239	CcSEcCtD
Caffeine—Dyspnoea—Sunitinib—pancreatic cancer	0.000147	0.00239	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000146	0.00237	CcSEcCtD
Caffeine—Renal failure—Docetaxel—pancreatic cancer	0.000145	0.00235	CcSEcCtD
Caffeine—CYP1A2—digestive system—pancreatic cancer	0.000144	0.0138	CbGeAlD
Caffeine—Hypertension—Irinotecan—pancreatic cancer	0.000144	0.00233	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—pancreatic cancer	0.000142	0.00231	CcSEcCtD
Caffeine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000142	0.00231	CcSEcCtD
Caffeine—CYP1A1—digestive system—pancreatic cancer	0.000142	0.0136	CbGeAlD
Caffeine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000142	0.0023	CcSEcCtD
Caffeine—Hypertension—Gemcitabine—pancreatic cancer	0.00014	0.00227	CcSEcCtD
Caffeine—CYP3A5—digestive system—pancreatic cancer	0.000139	0.0133	CbGeAlD
Caffeine—Convulsion—Fluorouracil—pancreatic cancer	0.000138	0.00224	CcSEcCtD
Caffeine—CYP2C9—digestive system—pancreatic cancer	0.000137	0.0131	CbGeAlD
Caffeine—Infection—Irinotecan—pancreatic cancer	0.000135	0.00219	CcSEcCtD
Caffeine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000133	0.00216	CcSEcCtD
Caffeine—Haemoglobin—Docetaxel—pancreatic cancer	0.000133	0.00216	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—pancreatic cancer	0.000132	0.00214	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000132	0.00214	CcSEcCtD
Caffeine—Infection—Gemcitabine—pancreatic cancer	0.000131	0.00213	CcSEcCtD
Caffeine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00013	0.00211	CcSEcCtD
Caffeine—CYP2E1—digestive system—pancreatic cancer	0.00013	0.0124	CbGeAlD
Caffeine—Infection—Fluorouracil—pancreatic cancer	0.000129	0.0021	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000129	0.00209	CcSEcCtD
Caffeine—Skin disorder—Gemcitabine—pancreatic cancer	0.000128	0.00209	CcSEcCtD
Caffeine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000127	0.00207	CcSEcCtD
Caffeine—Tachycardia—Fluorouracil—pancreatic cancer	0.000127	0.00206	CcSEcCtD
Caffeine—ABCB1—islet of Langerhans—pancreatic cancer	0.000123	0.0118	CbGeAlD
Caffeine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000123	0.00199	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000122	0.00198	CcSEcCtD
Caffeine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000121	0.00197	CcSEcCtD
Caffeine—Rash—Tamoxifen—pancreatic cancer	0.000121	0.00197	CcSEcCtD
Caffeine—Dermatitis—Tamoxifen—pancreatic cancer	0.000121	0.00197	CcSEcCtD
Caffeine—Dyspnoea—Irinotecan—pancreatic cancer	0.000121	0.00196	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000121	0.00196	CcSEcCtD
Caffeine—Rash—Erlotinib—pancreatic cancer	0.00012	0.00195	CcSEcCtD
Caffeine—Dermatitis—Erlotinib—pancreatic cancer	0.00012	0.00195	CcSEcCtD
Caffeine—Immune system disorder—Docetaxel—pancreatic cancer	0.000119	0.00194	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000119	0.00193	CcSEcCtD
Caffeine—Dry skin—Epirubicin—pancreatic cancer	0.000118	0.00192	CcSEcCtD
Caffeine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000118	0.00191	CcSEcCtD
Caffeine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000117	0.0019	CcSEcCtD
Caffeine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000116	0.00188	CcSEcCtD
Caffeine—Malnutrition—Docetaxel—pancreatic cancer	0.000115	0.00187	CcSEcCtD
Caffeine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000114	0.00185	CcSEcCtD
Caffeine—Gastritis—Epirubicin—pancreatic cancer	0.000114	0.00185	CcSEcCtD
Caffeine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000112	0.00182	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000112	0.00181	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—pancreatic cancer	0.000109	0.00177	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—pancreatic cancer	0.000105	0.00171	CcSEcCtD
Caffeine—CYP3A4—digestive system—pancreatic cancer	0.000104	0.00998	CbGeAlD
Caffeine—Rash—Sunitinib—pancreatic cancer	0.000104	0.00169	CcSEcCtD
Caffeine—Dermatitis—Sunitinib—pancreatic cancer	0.000104	0.00169	CcSEcCtD
Caffeine—CYP2D6—digestive system—pancreatic cancer	0.000103	0.00982	CbGeAlD
Caffeine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.0001	0.00163	CcSEcCtD
Caffeine—Hypersensitivity—Irinotecan—pancreatic cancer	0.0001	0.00162	CcSEcCtD
Caffeine—Convulsion—Docetaxel—pancreatic cancer	9.96e-05	0.00162	CcSEcCtD
Caffeine—Hypertension—Docetaxel—pancreatic cancer	9.92e-05	0.00161	CcSEcCtD
Caffeine—Infestation—Epirubicin—pancreatic cancer	9.92e-05	0.00161	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—pancreatic cancer	9.92e-05	0.00161	CcSEcCtD
Caffeine—Renal failure—Epirubicin—pancreatic cancer	9.75e-05	0.00158	CcSEcCtD
Caffeine—Hypersensitivity—Fluorouracil—pancreatic cancer	9.57e-05	0.00155	CcSEcCtD
Caffeine—Infection—Docetaxel—pancreatic cancer	9.32e-05	0.00151	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.28e-05	0.00151	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—pancreatic cancer	9.2e-05	0.00149	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—pancreatic cancer	9.18e-05	0.00149	CcSEcCtD
Caffeine—Infestation—Doxorubicin—pancreatic cancer	9.18e-05	0.00149	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—pancreatic cancer	9.15e-05	0.00149	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—pancreatic cancer	9.11e-05	0.00148	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—pancreatic cancer	9.02e-05	0.00147	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—pancreatic cancer	8.95e-05	0.00145	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—pancreatic cancer	8.9e-05	0.00145	CcSEcCtD
Caffeine—ABCB1—pancreas—pancreatic cancer	8.64e-05	0.00827	CbGeAlD
Caffeine—Rash—Irinotecan—pancreatic cancer	8.55e-05	0.00139	CcSEcCtD
Caffeine—Dermatitis—Irinotecan—pancreatic cancer	8.55e-05	0.00139	CcSEcCtD
Caffeine—Dyspnoea—Docetaxel—pancreatic cancer	8.36e-05	0.00136	CcSEcCtD
Caffeine—Rash—Gemcitabine—pancreatic cancer	8.33e-05	0.00135	CcSEcCtD
Caffeine—Dermatitis—Gemcitabine—pancreatic cancer	8.32e-05	0.00135	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—pancreatic cancer	8.28e-05	0.00134	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—pancreatic cancer	8.26e-05	0.00134	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—pancreatic cancer	8.24e-05	0.00134	CcSEcCtD
Caffeine—Rash—Fluorouracil—pancreatic cancer	8.19e-05	0.00133	CcSEcCtD
Caffeine—Dermatitis—Fluorouracil—pancreatic cancer	8.19e-05	0.00133	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	8.1e-05	0.00132	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—pancreatic cancer	8.04e-05	0.00131	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—pancreatic cancer	7.75e-05	0.00126	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—pancreatic cancer	7.65e-05	0.00124	CcSEcCtD
Caffeine—Nervousness—Epirubicin—pancreatic cancer	7.53e-05	0.00122	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—pancreatic cancer	7.44e-05	0.00121	CcSEcCtD
Caffeine—ABCB1—digestive system—pancreatic cancer	7.38e-05	0.00706	CbGeAlD
Caffeine—Malnutrition—Doxorubicin—pancreatic cancer	7.17e-05	0.00116	CcSEcCtD
Caffeine—Agitation—Epirubicin—pancreatic cancer	7.12e-05	0.00116	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—pancreatic cancer	6.97e-05	0.00113	CcSEcCtD
Caffeine—Hypersensitivity—Docetaxel—pancreatic cancer	6.91e-05	0.00112	CcSEcCtD
Caffeine—Convulsion—Epirubicin—pancreatic cancer	6.72e-05	0.00109	CcSEcCtD
Caffeine—Hypertension—Epirubicin—pancreatic cancer	6.69e-05	0.00109	CcSEcCtD
Caffeine—Agitation—Doxorubicin—pancreatic cancer	6.59e-05	0.00107	CcSEcCtD
Caffeine—Infection—Epirubicin—pancreatic cancer	6.28e-05	0.00102	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—pancreatic cancer	6.21e-05	0.00101	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—pancreatic cancer	6.2e-05	0.00101	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—pancreatic cancer	6.19e-05	0.00101	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—pancreatic cancer	6.17e-05	0.001	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—pancreatic cancer	6.14e-05	0.000998	CcSEcCtD
Caffeine—Rash—Docetaxel—pancreatic cancer	5.91e-05	0.00096	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—pancreatic cancer	5.91e-05	0.00096	CcSEcCtD
Caffeine—Infection—Doxorubicin—pancreatic cancer	5.81e-05	0.000944	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—pancreatic cancer	5.74e-05	0.000932	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—pancreatic cancer	5.71e-05	0.000928	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—pancreatic cancer	5.69e-05	0.000923	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—pancreatic cancer	5.64e-05	0.000916	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.46e-05	0.000887	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—pancreatic cancer	5.22e-05	0.000848	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.05e-05	0.000821	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—pancreatic cancer	4.66e-05	0.000757	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—pancreatic cancer	4.31e-05	0.0007	CcSEcCtD
Caffeine—Rash—Epirubicin—pancreatic cancer	3.99e-05	0.000648	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—pancreatic cancer	3.98e-05	0.000647	CcSEcCtD
Caffeine—Rash—Doxorubicin—pancreatic cancer	3.69e-05	0.000599	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—pancreatic cancer	3.69e-05	0.000599	CcSEcCtD
Caffeine—PIK3CA—Signaling Pathways—CASP3—pancreatic cancer	2.08e-06	1.96e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.08e-06	1.96e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MMP9—pancreatic cancer	2.08e-06	1.95e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTEN—pancreatic cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—pancreatic cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—APOE—pancreatic cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TGFB1—pancreatic cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.05e-06	1.93e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CD44—pancreatic cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—pancreatic cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—pancreatic cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TGFB1—pancreatic cancer	2.04e-06	1.92e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—pancreatic cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—pancreatic cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—pancreatic cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.01e-06	1.89e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—STK11—pancreatic cancer	2.01e-06	1.89e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PIK3CA—pancreatic cancer	2.01e-06	1.89e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CTNNB1—pancreatic cancer	2e-06	1.89e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2e-06	1.88e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—pancreatic cancer	2e-06	1.88e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARG—pancreatic cancer	1.99e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.98e-06	1.87e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—pancreatic cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP9—pancreatic cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—pancreatic cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GCG—pancreatic cancer	1.96e-06	1.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTEN—pancreatic cancer	1.95e-06	1.84e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—pancreatic cancer	1.94e-06	1.83e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SRC—pancreatic cancer	1.94e-06	1.82e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.93e-06	1.82e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.93e-06	1.81e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SRC—pancreatic cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—pancreatic cancer	1.91e-06	1.79e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—pancreatic cancer	1.9e-06	1.79e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	1.89e-06	1.78e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—pancreatic cancer	1.89e-06	1.78e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—pancreatic cancer	1.86e-06	1.76e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	1.86e-06	1.75e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.86e-06	1.75e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—pancreatic cancer	1.86e-06	1.75e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—STAT3—pancreatic cancer	1.85e-06	1.74e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—pancreatic cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—STK11—pancreatic cancer	1.84e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.83e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TYMS—pancreatic cancer	1.83e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.83e-06	1.72e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—pancreatic cancer	1.82e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SRC—pancreatic cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	1.81e-06	1.7e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.79e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.79e-06	1.69e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CD44—pancreatic cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—pancreatic cancer	1.76e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PIK3CA—pancreatic cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—STAT3—pancreatic cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—pancreatic cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—pancreatic cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—pancreatic cancer	1.74e-06	1.63e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TYMS—pancreatic cancer	1.73e-06	1.63e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	1.72e-06	1.62e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—pancreatic cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TGFB1—pancreatic cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—pancreatic cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GCG—pancreatic cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	1.7e-06	1.6e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—pancreatic cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—pancreatic cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—pancreatic cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	1.67e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CD44—pancreatic cancer	1.66e-06	1.57e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.65e-06	1.56e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—pancreatic cancer	1.64e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	1.63e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.63e-06	1.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—pancreatic cancer	1.62e-06	1.53e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	1.62e-06	1.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TGFB1—pancreatic cancer	1.62e-06	1.52e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—pancreatic cancer	1.62e-06	1.52e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—pancreatic cancer	1.61e-06	1.51e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.61e-06	1.51e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—STK11—pancreatic cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—pancreatic cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.6e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GCG—pancreatic cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—pancreatic cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—pancreatic cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.57e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—pancreatic cancer	1.56e-06	1.47e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.52e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.51e-06	1.42e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—pancreatic cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—STK11—pancreatic cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—APOE—pancreatic cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—APOE—pancreatic cancer	1.49e-06	1.4e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	1.47e-06	1.39e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.46e-06	1.37e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—pancreatic cancer	1.46e-06	1.37e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	1.44e-06	1.36e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	1.44e-06	1.35e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—pancreatic cancer	1.43e-06	1.35e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—pancreatic cancer	1.43e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CD44—pancreatic cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—pancreatic cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.42e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—pancreatic cancer	1.41e-06	1.33e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—pancreatic cancer	1.41e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.41e-06	1.32e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—APOE—pancreatic cancer	1.4e-06	1.32e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.38e-06	1.3e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.38e-06	1.3e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—pancreatic cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GCG—pancreatic cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—pancreatic cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—pancreatic cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.34e-06	1.26e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	1.34e-06	1.26e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.34e-06	1.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—pancreatic cancer	1.33e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.33e-06	1.25e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	1.31e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.3e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—pancreatic cancer	1.3e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—pancreatic cancer	1.29e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—APOE—pancreatic cancer	1.29e-06	1.21e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—STK11—pancreatic cancer	1.28e-06	1.21e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—pancreatic cancer	1.27e-06	1.2e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	1.27e-06	1.19e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—pancreatic cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—pancreatic cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	1.2e-06	1.13e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.2e-06	1.13e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—pancreatic cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.14e-06	1.07e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—pancreatic cancer	1.13e-06	1.06e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—APOE—pancreatic cancer	1.12e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—pancreatic cancer	1.12e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.1e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.06e-06	9.96e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	1.05e-06	9.91e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.05e-06	9.9e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—APOE—pancreatic cancer	1.05e-06	9.87e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	1.03e-06	9.7e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	1.03e-06	9.68e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	1.02e-06	9.62e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	1.02e-06	9.61e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	1.02e-06	9.59e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.01e-06	9.53e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.92e-07	9.34e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—STK11—pancreatic cancer	9.88e-07	9.3e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—pancreatic cancer	9.77e-07	9.2e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	9.71e-07	9.15e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—pancreatic cancer	9.62e-07	9.06e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	9.61e-07	9.05e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	9.54e-07	8.99e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	9.46e-07	8.91e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	9.29e-07	8.75e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—pancreatic cancer	9.21e-07	8.67e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—pancreatic cancer	9.13e-07	8.6e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—APOE—pancreatic cancer	8.95e-07	8.43e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	8.9e-07	8.39e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—pancreatic cancer	8.9e-07	8.38e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	8.9e-07	8.38e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—pancreatic cancer	8.88e-07	8.37e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	8.82e-07	8.31e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	8.67e-07	8.17e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—pancreatic cancer	8.5e-07	8e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.48e-07	7.98e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—pancreatic cancer	8.39e-07	7.9e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	8.39e-07	7.9e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	8.31e-07	7.83e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	8.08e-07	7.61e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—pancreatic cancer	7.85e-07	7.4e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—pancreatic cancer	7.8e-07	7.35e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	7.76e-07	7.31e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—pancreatic cancer	7.69e-07	7.25e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—pancreatic cancer	7.69e-07	7.24e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	7.31e-07	6.88e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	7.25e-07	6.83e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	7.24e-07	6.82e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	7.18e-07	6.76e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	7.1e-07	6.69e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—pancreatic cancer	7.08e-07	6.67e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—APOE—pancreatic cancer	6.91e-07	6.51e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—pancreatic cancer	6.7e-07	6.31e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—pancreatic cancer	6.32e-07	5.95e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	6.28e-07	5.91e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	6.27e-07	5.9e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—pancreatic cancer	6.26e-07	5.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	6.24e-07	5.87e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	6.19e-07	5.83e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	6.14e-07	5.78e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.02e-07	5.67e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	5.92e-07	5.58e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.48e-07	5.16e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	5.43e-07	5.11e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—pancreatic cancer	5.35e-07	5.04e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—pancreatic cancer	5.13e-07	4.83e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—pancreatic cancer	5.12e-07	4.82e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—pancreatic cancer	4.84e-07	4.56e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.78e-07	4.5e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.74e-07	4.46e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.73e-07	4.45e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.46e-07	4.2e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—pancreatic cancer	4.43e-07	4.18e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	4.42e-07	4.16e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.13e-07	3.89e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—pancreatic cancer	3.86e-07	3.64e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	3.78e-07	3.56e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.64e-07	3.43e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—pancreatic cancer	3.61e-07	3.4e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—pancreatic cancer	3.08e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.91e-07	2.74e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.38e-07	2.24e-06	CbGpPWpGaD
